cataract surgery. Disorder of vitreous body, unspecified
Conditions
Interventions
Intervention 1: Itravenous Lidocaine 2mg/kg. Intervention 2: normal saline (0.1 cc/kg).
Prevention
Placebo
Itravenous Lidocaine 2mg/kg
normal saline (0.1 cc/kg)
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with ASA I, II who were candidate for cataract surgery. Exclusion criteria: patients with history of heart blocks, taking anti IOP drugs and the ones who needed general anesthesia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure (IOP). Timepoint: 5 min before the operation and 3 min after injecting Lidocaine or placebo. Method of measurement: using Tonometer PT100 model protable non contact. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' heart rate, blood pressure and SPO2. Timepoint: 5 min before the operation and 3 min after injecting Lidocaine or the placebo. Method of measurement: using monitoring mechine Passport II. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mitra Yari
Kermanshah University of Medical Sciences
Outcome results
None listed